Ravi Vij, M.D.

Original Manuscripts

• Martin MG, Augustin KM, Uy GL, Welch JS, Hladnik L, Goyal S, Tiwari D, Monahan RS, Reichley RM, Cashen AF, Stockerl-Goldstein K, Westervelt P, Abboud CN, DiPersio JF, Vij R
  Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
  Am J Hematol 2009 Sep 11; [Epub ahead of print]
• Vij R, Horvath N, Spencer A, Taylor K, Vadhan-Raj S, Vescio R, Smith J, Qian Y, Yeh H, Jun S
  An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma.
  Am J Hematol 2009 Jul 25; [Epub ahead of print]
• Martin MG, Walgren RA, Procknow E, Uy GL, Stockerl-Goldstein K, Cashen AF, Westervelt P, Abboud CN, Kreisel F, Augustin K, DiPersio JF, Vij R
  A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
  Am J Hematol 2009 Sep;84(9):560-4
• Martin MG, Vij R
  Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature.
  Clin Lymphoma Myeloma 2009 Aug;9(4):320-3
• Langer C, Marcucci G, Holland KB, Radmacher MD, Maharry K, Paschka P, Whitman SP, Mrozek K, Baldus CD, Vij R, Powell BL, Carroll AJ, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD
  Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
  J Clin Oncol 2009 Jul 1;27(19):3198-204
• Martin MG, Uy GL, Procknow E, Stockerl-Goldstein K, Cashen A, Westervelt P, Abboud CN, Augustin K, Luo J, DiPersio JF, Vij R
  Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.
  Bone Marrow Transplant 2009 Jul;44(1):13-7
• Uy GL, Goyal SD, Fisher NM, Oza AY, Tomasson MH, Stockerl-Goldstein K, DiPersio JF, Vij R
  Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
  Bone Marrow Transplant 2009 May;43(10):793-800
• Ramsingh G, Mehan P, Morgensztern D, Luo J, Vij R
  Prognostic factors influencing survival in solitary plasmacytoma.
  Br J Haematol 2009 May;145(4):540-2
• Wildes TM, Procknow E, Gao F, DiPersio JF, Vij R
  Dasatinib in relapsed or plateau-phase multiple myeloma.
  Leuk Lymphoma 2009 Jan;50(1):137-40
• O'Neal J, Gao F, Hassan A, Monahan R, Barrios S, Lee I, Chng WJ, Vij R, Tomasson MH
  Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.
  Exp Hematol 2009 Feb;37(2):234-44
• Fehniger TA, Byrd JC, Marcucci G, Abboud CN, Kefauver C, Payton JE, Vij R, Blum W
  Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.
  Blood 2009 Jan 29;113(5):1002-5
• Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF
  Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
  Biol Blood Marrow Transplant 2008 Sep;14(9):1045-56
• Devine SM, Vij R, Rettig M, Todt L, McGlauchlen K, Fisher N, Devine H, Link DC, Calandra G, Bridger G, Westervelt P, Dipersio JF
  Rapid mobilization of functional donor hematopoietic cells without G-CSF using plerixafor, an antagonist of the CXCR4/SDF-1 interaction.
  Blood 2008 Aug 15;112(4):990-8
• Winston DJ, Young JA, Pullarkat V, Papanicolaou GA, Vij R, Vance E, Alangaden GJ, Chemaly RF, Petersen F, Chao N, Klein J, Sprague K, Villano SA, Boeckh M
  Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.
  Blood 2008 Jun 1;111(11):5403-10
• Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF, Devine SM
  Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.
  Biol Blood Marrow Transplant 2008 Jul;14(7):840-6
• Uy GL, Trivedi R, Peles S, Fisher NM, Zhang QJ, Tomasson MH, DiPersio JF, Vij R
  Bortezomib inhibits osteoclast activity in patients with multiple myeloma.
  Clin Lymphoma Myeloma 2007 Nov;7(9):587-9
• Fong T, Trinkaus K, Adkins D, Vij R, Devine SM, Tomasson M, Goodnough LT, Lopez S, Graubert T, Shenoy S, Dipersio JF, Khoury HJ
  A Randomized Double-Blind Trial of Hydroxychloroquine for the Prevention of Chronic Graft-versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.
  Biol Blood Marrow Transplant 2007 Oct;13(10):1201-6
• Tiwari D, Gao F, Hidalgo J, Adkins DR, Vij R, Dipersio JF, Khoury HJ
  Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma.
  Bone Marrow Transplant 2007 Oct;40(7):671-5
• Fong T, Vij R, Vijayan A, DiPersio J, Blinder M
  Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome.
  Haematologica 2007 Oct;92(10):1429-30
• Uy GL, Tomasson MH, Ruddell A, DiPersio JF, Vij R
  The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma.
  Haematologica 2006 Nov;91(11):1581-2
• Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR
  Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
  Biol Blood Marrow Transplant 2006 Jul;12(7):749-57
• Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, Augustin K, Vij R, Trinkaus K, Dipersio JF, Adkins D
  Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
  Transfusion 2006 Jan;46(1):14-23
• Verkruyse LA, Storch GA, Devine SM, Dipersio JF, Vij R
  Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.
  Bone Marrow Transplant 2006 Jan;37(1):51-6
• Brenner W, Storch G, Buller R, Vij R, Devine S, DiPersio J
  West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance.
  Bone Marrow Transplant 2005 Aug;36(4):369-70
• Devine SM, Brown RA, Mathews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough LT, DiPersio JF
  Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
  Bone Marrow Transplant 2005 Sep;36(6):531-8
• Friedman J, Khoury H, Adkins D, Devine S, Nervi B, Edwards T, Dipersio J, Vij R
  Pilot study of 13cis-retinoic acid+dexamethasone+alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma.
  Bone Marrow Transplant 2005 May;35(10):979-84
• Girgis M, Hallemeier C, Blum W, Brown R, Lin HS, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Oza A, Dipersio J, Adkins D
  Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.
  Blood 2005 Apr 15;105(8):3035-41
• Hoerr AL, Gao F, Hidalgo J, Tiwari D, Blum KA, Mathews V, Adkins DR, Blum W, Devine S, Vij R, Goodnough LT, Dipersio JF, Khoury HJ
  Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.
  J Clin Oncol 2004 Nov 15;22(22):4561-6
• Hallemeier C, Girgis M, Khoury H, Devine S, Blum W, Vij R, Lin H-S, DiPersio J, Adkins D
  Re: High rate of graft failure in 25 patients with chronic myelogenous leukemia conditioned with a reduced-intensity regimen of 550 cGy total body irradiation and cyclophosphamide for unrelated donor transplantation.
  Biol Blood Marrow Transplant 2004 Oct;10(10):726-7
• Hidalgo JD, Krone R, Rich MW, Blum K, Adkins D, Fan MY, Brown R, Devine S, Graubert T, Blum W, Tomasson M, Goodnough LT, Vij R, DiPersio J, Khoury H
  Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.
  Bone Marrow Transplant 2004 Oct;34(7):615-9
• Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D
  Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
  Biol Blood Marrow Transplant 2004 May;10(5):310-9
• Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, Dipersio JF
  Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation.
  Biol Blood Marrow Transplant 2003 Nov;9(11):714-21
• Devine SM, Adkins DR, Khoury H, Brown RA, Vij R, Blum W, DiPersio JF
  Recent advances in allogeneic hematopoietic stem-cell transplantation.
  J Lab Clin Med 2003 Jan;141(1):7-32
• Chohan R, Vij R, Adkins D, Blum W, Brown R, Tomasson M, Devine S, Graubert T, Goodnough LT, DiPersio JF, Khoury H
  Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
  Br J Haematol 2003 Oct;123(1):110-3
• Blum W, Khoury H, Lin HS, Vij R, Goodnough LT, Devine S, Dipersio J, Adkins D
  Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility study.
  Biol Blood Marrow Transplant 2003 Jun;9(6):397-404
• Vij R, Khoury H, Brown R, Goodnough LT, Devine SM, Blum W, Adkins D, DiPersio JF
  Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation.
  Bone Marrow Transplant 2003 Oct;32(7):703-7
• Vij R, DiPersio J, Khoury H, Goodnough LT, Devine SM, Blum W, Adkins D
  Granulocyte transfusions and cytomegalovirus infection.
  Blood 2003;101(12):5091-2
• Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, Khoury HJ, Devine SM, Oza A, Shenoy S, Blum W, Adkins D
  Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.
  Blood 2003 Mar 1;101(5):2067-9
• Blum W, Brown R, Lin HS, Zehnbauer B, Khoury H, Goodnough LT, Westervelt P, Vij R, DiPersio J, Adkins D
  Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.
  Biol Blood Marrow Transplant 2002;8(11):608-18
• Khoury H, Adkins D, Brown R, Pence H, Vij R, Goodnough LT, Westervelt P, Trinkaus K, Lin HS, DiPersio Y
  Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen.
  Biol Blood Marrow Transplant 2001;7(6):352-8
• Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, Westervelt P, Trinkaus K, Goodnough LT, Hayashi RJ, Parker P, Forman SJ, DiPersio JF
  Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin.
  Bone Marrow Transplant 2001 May;27(10):1059-64
• Khoury H, Adkins D, Brown R, Vij R, Westervelt P, Trinkaus K, Goodnough LT, DiPersio JF
  Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.
  Bone Marrow Transplant 2000 Jun;25(11):1197-201
• Adkins DR, Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H, Vij R, DiPersio J
  Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.
  Blood 2000 Jun 1;95(11):3605-12
• Adkins DR, Abidi MH, Brown RA, Khoury H, Goodnough LT, Vij R, Westervelt P, DiPersio JF
  Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
  Bone Marrow Transplant 2000 Dec;26(11):1239-41
• DiPersio JF, Khoury H, Haug J, Vij R, Adkins DR, Goodnough LT, Brown RA
  Innovations in allogeneic stem-cell transplantation.
  Semin Hematol 2000 Jan;37(1 Suppl 2):33-41
• Khoury H, Adkins D, Brown R, Trinkaus K, Vij R, Miller G, Goodnough LT, DiPersio J
  Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
  Bone Marrow Transplant 2000 Apr;25(7):737-43
• Vij R, DiPersio J, Brown R, Trinkaus K, Abboud C, Meehan KR, Frenette G, Freytes C, Goodnough LT, Khoury H, Ponnuri J, Adkins D
  Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.
  Bone Marrow Transplant 2000 Nov;26(9):947-53
• Vij R, Brown R, Shenoy S, Haug JS, Kaesberg D, Adkins D, Goodnough LT, Khoury H, DiPersio J
  Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation.
  Bone Marrow Transplant 2000 Jun;25(12):1223-8
• Brown RA, Adkins D, Khoury H, Vij R, Goodnough LT, Shenoy S, DiPersio JF
  Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality.
  J Clin Oncol 1999 Mar;17(3):806-12
• Adkins D, Brown R, Trinkaus K, Maziarz R, Luedke S, Freytes C, Needles B, Wienski D, Fracasso P, Pluard T, Moriconi W, Ryan T, Hoelzer K, Safdar S, Rearden T, Rodriguez G, Khoury H, Vij R, DiPersio J
  Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.
  J Clin Oncol 1999 Jul;17(7):2006-14
• Vij R, Adkins DR, Brown RA, Khoury H, DiPersio JF, Goodnough T
  Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony-stimulating factor.
  Transfusion 1999 May;39(5):542-3